Harrington Discovery Institute Panel at Morgan Stanley’s The Exchange 2019
On June 4, 2019 Morgan Stanley announced an exciting new collaboration with Harrington Discovery Institute at The Exchange 2019, a two-day event in New York City presented by The Social Impact Exchange and Morgan Stanley. Through a new partnership with Morgan Stanley Global Impact Funding Trust (GIFT), Harrington Discovery Institute is transforming the way philanthropy supports the development of new medicines. Morgan Stanley GIFT Cures powered by Harrington Discovery Institute is a special interest program for philanthropists to amplify their impact by accelerating cures for multiple diseases.
The collaboration was announced during a panel session titled “The Future of Medicine,” comprised of key players in the new partnership and representatives of the unique Harrington Discovery Institute model. The panel was moderated by Melanie Schnoll Begun, Managing Director and Head of Philanthropy Management for Morgan Stanley Wealth Management and President of the Morgan Stanley Global Impact Funding Trust. The distinguished panel included:
- Mr. Ron Harrington, Entrepreneur and Philanthropist
- Dr. Jonathan Stamler, President, Harrington Discovery Institute
- Prof. Georg Holländer, Hoffman and Action Medical Research Professor of Developmental Medicine at the University of Oxford
- Dr. Nicole Calakos, Professor, Neurology and Neurobiology, Duke University Medical Center, and Harrington Scholar
- Dr. Stephen Brenner, Strategic Advisor, Therapeutics Development team, Harrington Discovery Institute
The audience included philanthropic funders, individual donors, leading nonprofits, and family offices. Discussed was the opportunity for collaboration among physicians, academics, entrepreneurs and philanthropists to build a scalable solution that addresses the “Valley of Death” in drug development: the obstacles that prevent innovative medical research discoveries from ever reaching clinical trials or becoming new therapies.